Pharmafile Logo
Pharmafocus logo
Advanced Search

Clayton

Showing 3 posts of 3 posts found.

Sanofi and CD&R finalise Opella deal, launching global consumer healthcare giant

May 6, 2025
Mergers and Acquisitions (OTC & VMS), Clayton, Clayton Dubilier & Rice (CD&R), Corporate, M&A, Opella, Sanofi, agreement

Sanofi and Clayton, Dubilier & Rice (CD&R) have officially closed the sale of a controlling 50% stake in Opella, Sanofi’s …

News
novo_flag

Novo Nordisk breaks ground on new $2 billion production facility in North Carolina

March 29, 2016
Manufacturing and Production, Research and Development $2 billion, Clayton, Novo, Novo Nordisk, building, diabetes, nordisk, north carolina, production facility

Novo Nordisk has begun work on a new $2 billion production facility in Clayton, North Carolina, which will produce active …

News
Hospira image

Hospira closing US manufacturing plant

January 20, 2015
Manufacturing and Production, Sales and Marketing Clayton, Hospira, Novo Nordisk, Vancomycin hydrochloride, illinois, manufacturing

US injectable drugs specialist Hospira is to close its Clayton plant in North Carolina affecting 250 workers. Manufacturing of products …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025